戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 e glycosaminoglycan is made predominantly of chondroitin 4-sulfate.
2 an sulfate, heparan sulfate, chondroitin, or chondroitin 4-sulfate.
3 ted that Ihh interacts with CS, particularly chondroitin-4-sulfate.
4 using heparins of different size, as well as chondroitin 4-sulfate and dermatan sulfate as the GAG po
5 -sulfate groups from the non-reducing end of chondroitin 4-sulfate and dermatan sulfate.
6 SP contains glycosaminoglycan chains made of chondroitin-4-sulfate and has an average of 31-32 disacc
7 ycosaminoglycan polyanions, such as heparin, chondroitin 4-sulfate, and dermatan sulfate.
8 ratan sulfate) may catalyze the sulfation of chondroitin 4-sulfate as alternative substrate.
9 sizes chondroitin 6-sulfate rather than only chondroitin 4-sulfate as wild-type cells.
10 oint to glycosaminoglycans, and specifically chondroitin 4-sulfates, as a novel class of immunologica
11 oiting pregnant rats as a model for studying chondroitin 4-sulfate-based therapeutics for human place
12                           In the presence of chondroitin-4-sulfate (C-4S), the CA value increased 200
13                    We have demonstrated that chondroitin 4-sulfate (C4-S) promotes autoprocessing of
14 rtilage-resident glycosaminoglycans, such as chondroitin 4-sulfate (C4-S).
15                                          The chondroitin 4-sulfate (C4S) chains of very low sulfated
16 A dodecasaccharide motif of the low-sulfated chondroitin 4-sulfate (C4S) mediate the binding of Plasm
17  protein 1 named VAR2CSA to the low sulfated chondroitin 4-sulfate (C4S) proteoglycan (CSPG) present
18 quirements for the adherence and the minimum chondroitin 4-sulfate (C4S) structural motif that suppor
19 rageenan (1 mug/ml for 24 h), degradation of chondroitin 4-sulfate (C4S) was inhibited, leading to ac
20        Content of total sulfated GAG (sGAG), chondroitin 4-sulfate (C4S), and total chondroitin sulfa
21 ls (IRBCs) sequester in the placenta through chondroitin 4-sulfate (C4S)-mediated adherence.
22 loss of parasitized erythrocytes adhering to chondroitin 4-sulfate (C4S).
23 lfatase; ARSB) removes 4-sulfate groups from chondroitin-4-sulfate (C4S) and dermatan sulfate and is
24 's dermatomyositis (DM) lesions is primarily chondroitin-4-sulfate (C4S), which is immunomodulatory i
25 (IRBCs) in the human placenta is mediated by chondroitin-4-sulfate (C4S).
26  [HA] and chondroitin [C0S]), sulfated GAGs (chondroitin-4-sulfate [C4S], chondroitin-6-sulfate [C6S]
27 tes sequester in the placenta by adhering to chondroitin 4-sulfate, creating a risk factor for both t
28 roteoglycan, namely serglycin, that contains chondroitin 4-sulfate (CS) glycosaminoglycans is present
29                                          The chondroitin-4-sulfate (CS) chain attached to Ser(10) was
30 C digestion (P < .05) and by the addition of chondroitin-4-sulfate (CS) or heparin in excess quantiti
31     First, sulfated oligosaccharides such as chondroitin-4-sulfate (CS) were efficiently isolated fro
32  in the order of heparin > heparan sulfate > chondroitin-4-sulfate = dermatan sulfate = dextran sulfa
33              In this study, we show that two chondroitin 4-sulfate forms, CSA and CSB, can activate d
34 hesion of infected erythrocytes to placental chondroitin 4-sulfate in primigravid women.
35 SA, a PfEMP1 that mediates IRBC adherence to chondroitin 4-sulfate in the placenta.
36  in the area, suggesting multiple origins of chondroitin-4-sulfate increase.
37                                     Although chondroitin 4-sulfate is known to mediate IRBC adherence
38 m infection in pregnant women results in the chondroitin 4-sulfate-mediated adherence of the parasite
39 eceptors for IRBC adhesion, which involves a chondroitin 4-sulfate motif consisting of six disacchari
40                                              Chondroitin 4-sulfate proteoglycans constitute the predo
41  an increase in the chondroitin-6-sulfate to chondroitin-4-sulfate ratio of GAG chains on versican, a
42   Chondroitin sulfate A (CS-A, also known as chondroitin-4-sulfate) was used as the substrate for the
43 igher concentrations of dermatan sulfate and chondroitin 4-sulfate were required with an IC(50) of 2,

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。